Invea Therapeutics, Inc. (INAI)

Invea Therapeutics was planning to go public, but the IPO was withdrawn on Mar 29, 2024.

Stock Price: Pending

IPO price not available yet

Invea Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021
Debt / Equity Ratio	-0.27	-0.25	-0.63
Debt / EBITDA Ratio	-0.41	-0.32	-0.32
Debt / FCF Ratio	-0.62	-0.35	-0.38
Quick Ratio	0.07	0.20	0.65
Interest Coverage	-94.81	-111.80	-
Return on Equity (ROE)	67.14%	79.18%	194.35%
Return on Assets (ROA)	-	-731.00%	-910.58%
Return on Capital (ROIC)	81.29%	104.60%	518.65%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).